Logo image of DXC

DXC TECHNOLOGY CO (DXC) Stock Fundamental Analysis

NYSE:DXC - New York Stock Exchange, Inc. - US23355L1061 - Common Stock - Currency: USD

15.03  -0.17 (-1.12%)

After market: 15.1 +0.07 (+0.47%)

Fundamental Rating

3

Taking everything into account, DXC scores 3 out of 10 in our fundamental rating. DXC was compared to 82 industry peers in the IT Services industry. While DXC is still in line with the averages on profitability rating, there are concerns on its financial health. DXC is valued quite cheap, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

DXC had positive earnings in the past year.
DXC had a positive operating cash flow in the past year.
In multiple years DXC reported negative net income over the last 5 years.
Each year in the past 5 years DXC had a positive operating cash flow.
DXC Yearly Net Income VS EBIT VS OCF VS FCFDXC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B -4B

1.2 Ratios

The Return On Assets of DXC (2.95%) is comparable to the rest of the industry.
The Return On Equity of DXC (12.05%) is better than 70.73% of its industry peers.
DXC has a Return On Invested Capital (3.17%) which is comparable to the rest of the industry.
DXC had an Average Return On Invested Capital over the past 3 years of 2.61%. This is significantly below the industry average of 21.64%.
The last Return On Invested Capital (3.17%) for DXC is above the 3 year average (2.61%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.95%
ROE 12.05%
ROIC 3.17%
ROA(3y)0.01%
ROA(5y)0.58%
ROE(3y)-0.32%
ROE(5y)2.05%
ROIC(3y)2.61%
ROIC(5y)N/A
DXC Yearly ROA, ROE, ROICDXC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40 -60 -80 -100

1.3 Margins

DXC has a Profit Margin of 3.02%. This is comparable to the rest of the industry: DXC outperforms 53.66% of its industry peers.
DXC's Profit Margin has declined in the last couple of years.
The Operating Margin of DXC (3.81%) is comparable to the rest of the industry.
DXC's Operating Margin has declined in the last couple of years.
DXC has a worse Gross Margin (24.09%) than 71.95% of its industry peers.
In the last couple of years the Gross Margin of DXC has remained more or less at the same level.
Industry RankSector Rank
OM 3.81%
PM (TTM) 3.02%
GM 24.09%
OM growth 3Y8.71%
OM growth 5Y-14.76%
PM growth 3Y-11.86%
PM growth 5YN/A
GM growth 3Y3.04%
GM growth 5Y0.17%
DXC Yearly Profit, Operating, Gross MarginsDXC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 -20

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so DXC is destroying value.
The number of shares outstanding for DXC has been increased compared to 1 year ago.
The number of shares outstanding for DXC has been reduced compared to 5 years ago.
The debt/assets ratio for DXC has been reduced compared to a year ago.
DXC Yearly Shares OutstandingDXC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
DXC Yearly Total Debt VS Total AssetsDXC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

Based on the Altman-Z score of 0.98, we must say that DXC is in the distress zone and has some risk of bankruptcy.
DXC has a Altman-Z score of 0.98. This is in the lower half of the industry: DXC underperforms 70.73% of its industry peers.
The Debt to FCF ratio of DXC is 5.64, which is a neutral value as it means it would take DXC, 5.64 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of DXC (5.64) is comparable to the rest of the industry.
A Debt/Equity ratio of 1.15 is on the high side and indicates that DXC has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.15, DXC is doing worse than 70.73% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.15
Debt/FCF 5.64
Altman-Z 0.98
ROIC/WACC0.4
WACC7.91%
DXC Yearly LT Debt VS Equity VS FCFDXC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B

2.3 Liquidity

DXC has a Current Ratio of 1.22. This is a normal value and indicates that DXC is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.22, DXC is doing worse than 68.29% of the companies in the same industry.
A Quick Ratio of 1.22 indicates that DXC should not have too much problems paying its short term obligations.
DXC has a Quick ratio of 1.22. This is in the lower half of the industry: DXC underperforms 67.07% of its industry peers.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 1.22
DXC Yearly Current Assets VS Current LiabilitesDXC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 8.20% over the past year.
DXC shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.24% yearly.
The Revenue has decreased by -5.82% in the past year.
DXC shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -8.05% yearly.
EPS 1Y (TTM)8.2%
EPS 3Y-0.58%
EPS 5Y-9.24%
EPS Q2Q%-13.4%
Revenue 1Y (TTM)-5.82%
Revenue growth 3Y-7.5%
Revenue growth 5Y-8.05%
Sales Q2Q%-6.41%

3.2 Future

The Earnings Per Share is expected to decrease by -3.62% on average over the next years.
DXC is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -3.48% yearly.
EPS Next Y-11.54%
EPS Next 2Y-3.89%
EPS Next 3Y-3.62%
EPS Next 5YN/A
Revenue Next Year-4.31%
Revenue Next 2Y-3.66%
Revenue Next 3Y-3.48%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
DXC Yearly Revenue VS EstimatesDXC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B 20B
DXC Yearly EPS VS EstimatesDXC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 4.38, the valuation of DXC can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of DXC indicates a rather cheap valuation: DXC is cheaper than 97.56% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of DXC to the average of the S&P500 Index (26.92), we can say DXC is valued rather cheaply.
The Price/Forward Earnings ratio is 4.95, which indicates a rather cheap valuation of DXC.
Based on the Price/Forward Earnings ratio, DXC is valued cheaply inside the industry as 95.12% of the companies are valued more expensively.
DXC's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.49.
Industry RankSector Rank
PE 4.38
Fwd PE 4.95
DXC Price Earnings VS Forward Price EarningsDXC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

DXC's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. DXC is cheaper than 97.56% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of DXC indicates a rather cheap valuation: DXC is cheaper than 98.78% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 3.97
EV/EBITDA 2.29
DXC Per share dataDXC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

A cheap valuation may be justified as DXC's earnings are expected to decrease with -3.62% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.89%
EPS Next 3Y-3.62%

0

5. Dividend

5.1 Amount

No dividends for DXC!.
Industry RankSector Rank
Dividend Yield N/A

DXC TECHNOLOGY CO

NYSE:DXC (6/27/2025, 8:04:00 PM)

After market: 15.1 +0.07 (+0.47%)

15.03

-0.17 (-1.12%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)05-14 2025-05-14/amc
Earnings (Next)08-06 2025-08-06/amc
Inst Owners91.96%
Inst Owner Change-2.91%
Ins Owners0.88%
Ins Owner Change13.73%
Market Cap2.72B
Analysts49.41
Price Target18.19 (21.02%)
Short Float %4.17%
Short Ratio4.32
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.89%
Min EPS beat(2)7.63%
Max EPS beat(2)18.16%
EPS beat(4)4
Avg EPS beat(4)20.14%
Min EPS beat(4)7.63%
Max EPS beat(4)28.05%
EPS beat(8)7
Avg EPS beat(8)10.86%
EPS beat(12)9
Avg EPS beat(12)7.51%
EPS beat(16)11
Avg EPS beat(16)5.76%
Revenue beat(2)1
Avg Revenue beat(2)-0.79%
Min Revenue beat(2)-1.74%
Max Revenue beat(2)0.16%
Revenue beat(4)3
Avg Revenue beat(4)0.18%
Min Revenue beat(4)-1.74%
Max Revenue beat(4)2.02%
Revenue beat(8)4
Avg Revenue beat(8)-0.59%
Revenue beat(12)4
Avg Revenue beat(12)-0.79%
Revenue beat(16)4
Avg Revenue beat(16)-1.11%
PT rev (1m)-15.26%
PT rev (3m)-22%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-20.13%
EPS NY rev (1m)-1.07%
EPS NY rev (3m)-12.12%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.96%
Revenue NY rev (1m)-0.89%
Revenue NY rev (3m)-0.51%
Valuation
Industry RankSector Rank
PE 4.38
Fwd PE 4.95
P/S 0.21
P/FCF 3.97
P/OCF 1.95
P/B 0.84
P/tB 2.57
EV/EBITDA 2.29
EPS(TTM)3.43
EY22.82%
EPS(NY)3.03
Fwd EY20.19%
FCF(TTM)3.79
FCFY25.22%
OCF(TTM)7.71
OCFY51.31%
SpS71
BVpS17.81
TBVpS5.85
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.95%
ROE 12.05%
ROCE 5.58%
ROIC 3.17%
ROICexc 3.91%
ROICexgc 5.44%
OM 3.81%
PM (TTM) 3.02%
GM 24.09%
FCFM 5.34%
ROA(3y)0.01%
ROA(5y)0.58%
ROE(3y)-0.32%
ROE(5y)2.05%
ROIC(3y)2.61%
ROIC(5y)N/A
ROICexc(3y)3.12%
ROICexc(5y)N/A
ROICexgc(3y)4.53%
ROICexgc(5y)N/A
ROCE(3y)4.4%
ROCE(5y)N/A
ROICexcg growth 3Y8.66%
ROICexcg growth 5Y-17.32%
ROICexc growth 3Y13.16%
ROICexc growth 5Y-10.47%
OM growth 3Y8.71%
OM growth 5Y-14.76%
PM growth 3Y-11.86%
PM growth 5YN/A
GM growth 3Y3.04%
GM growth 5Y0.17%
F-Score8
Asset Turnover0.97
Health
Industry RankSector Rank
Debt/Equity 1.15
Debt/FCF 5.64
Debt/EBITDA 2.05
Cap/Depr 54.15%
Cap/Sales 5.52%
Interest Coverage 1.9
Cash Conversion 77.49%
Profit Quality 176.61%
Current Ratio 1.22
Quick Ratio 1.22
Altman-Z 0.98
F-Score8
WACC7.91%
ROIC/WACC0.4
Cap/Depr(3y)46.69%
Cap/Depr(5y)44.53%
Cap/Sales(3y)4.88%
Cap/Sales(5y)4.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8.2%
EPS 3Y-0.58%
EPS 5Y-9.24%
EPS Q2Q%-13.4%
EPS Next Y-11.54%
EPS Next 2Y-3.89%
EPS Next 3Y-3.62%
EPS Next 5YN/A
Revenue 1Y (TTM)-5.82%
Revenue growth 3Y-7.5%
Revenue growth 5Y-8.05%
Sales Q2Q%-6.41%
Revenue Next Year-4.31%
Revenue Next 2Y-3.66%
Revenue Next 3Y-3.48%
Revenue Next 5YN/A
EBIT growth 1Y-11.37%
EBIT growth 3Y0.55%
EBIT growth 5Y-21.62%
EBIT Next Year77.76%
EBIT Next 3Y19.27%
EBIT Next 5YN/A
FCF growth 1Y-9.13%
FCF growth 3Y-4.75%
FCF growth 5Y-14.28%
OCF growth 1Y2.72%
OCF growth 3Y-3.44%
OCF growth 5Y-9.87%